中國大冶有色金屬(00661.HK)盈喜:預計年度溢利大幅增長
格隆匯3月20日丨中國大冶有色金屬(00661.HK)宣佈,公司預計相對於上年度,集團截至2023年12月31日止年度將錄得溢利大幅增長。
董事會認為,預期集團該年度的收入大幅增長主要由於2023年公司非全資附屬公司陽新弘盛銅業有限公司正式投產後,公司主要產品陰極銅、黃金產量同比增加。預期集團該年度的溢利大幅增長主要是由於陽新弘盛2023年實現投產即達產,實現較高淨利潤,影響集團淨利潤大幅增加。
監於上文所述,董事會預期該年度收入約為人民幣44,784,723,000元,同比增加約33.06%,年內溢利約人民幣202,496,000元,同比增加約人民幣208,912,000元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.